系统性与按需早期姑息治疗:评估临终前医疗质量与治疗积极性的随机临床试验
该研究为一项随机试验的二次分析,纳入207例转移性胰腺癌门诊患者,随机分为标准抗肿瘤治疗加按需早期姑息治疗(标准组)或加系统性早期姑息治疗(干预组)。随访20个月后149例(80%)死亡。系统性早期姑息治疗在部分临终治疗积极性指标上显示有利影响,包括临终关怀服务使用更多、生命最后30天内化疗比例更低(18.7%对27.8%,校正P=0.036)。
要点
- 系统性早期姑息治疗组临终关怀服务使用时间更长、入院次数更多(P=0.025和P<0.010)。
- 干预组生命最后30天内化疗比例为18.7%,标准组为27.8%(校正P=0.036)。
- 其他多数指标差异无统计学意义,但作者认为医疗质量有所改善。
核心结论
- 系统性早期姑息治疗对部分临终治疗积极性指标有显著影响,作者认为该方式改善了医疗质量。
研究设计与样本
- 该研究为一项随机临床试验的二次分析,纳入207例转移性胰腺癌门诊患者,随机分配至标准抗肿瘤治疗加按需早期姑息治疗(标准组)或标准抗肿瘤治疗加系统性早期姑息治疗(干预组)。
- 随访20个月后,149例(80%)患者死亡。
主要发现
- 干预组临终关怀服务使用的中位时间和平均时间均显著更长(两项指标P=0.025)。
- 干预组临终关怀入院的中位数和平均数均显著更高(两项P<0.010)。
- 干预组生命最后30天内化疗比例为18.7%,标准组为27.8%(校正P=0.036)。
- 其他指标差异无统计学意义,但多数倾向于干预组。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: Early palliative care (EPC) in oncology has shown sparse evidence of a positive impact on patient outcomes, quality of care outcomes and costs. PATIENTS AND METHODS: Data for this secondary analysis were taken from a trial of 207 outpatients with metastatic pancreatic cancer randomly assigned to receive standard cancer care plus on-demand EPC (standard arm) or standard cancer care plus systematic EPC (interventional arm). After 20 months' follow-up, 149 (80%) had died. Outcome measures were frequency, type and timing of chemotherapy administration, use of resources, place of death and overall survival. RESULTS: Some indices of end-of-life (EoL) aggressiveness had a favourable impact from systematic EPC. Interventional arm patients showed higher use of hospice services: a significantly longer median and mean period of hospice care (P = 0.025 for both indexes) and a significantly higher median and mean number of hospice admissions (both P < 0.010). In the experimental arm, chemotherapy was performed in the last 30 days of life in a significantly inferior rate with respect to control arm: 18.7% versus 27.8% (adjusted P = 0.036). Other non-significant differences were seen in favour of experimental arm. CONCLUSIONS: Systematic EPC showed a significant impact on some indicators of EoL treatment aggressiveness. These data, reinforced by multiple non-significant differences in most of the other items, suggest that quality of care is improved by this approach. This study is registered on ClinicalTrials.gov (NCT01996540).
引用
- Maltoni M, Scarpi E, Dall'Agata M, et al. Systematic versus on-demand early palliative care: A randomised clinical trial assessing quality of care and treatment aggressiveness near the end of life. Eur J Cancer. 2016. PMID: 27821313. doi:10.1016/j.ejca.2016.10.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。